1. ABOUT US

    #

    about us

    Our business research and market analysis helps organizations across different industry verticals solve their business problems. We are always scrupulous about our work and provide customized market research reports revealing the hidden truths on different verticals like pharmaceutical, oil and gas, telecommunications, real estate, logistics, energy, healthcare, technology, FMCG, food & beverages and media sectors.

    Read More
  2. RESEARCH REPORTS

    RESEARCH REPORTS

    RESEARCH REPORTS

    Our business research and market analysis helps organizations across different industry verticals solve their business problems. We are always scrupulous about our work and provide customized market research reports revealing the hidden truths on different verticals like pharmaceutical, oil and gas, telecommunications, real estate, logistics, energy, healthcare, technology, FMCG, food & beverages and media sectors.

    Read More
  3. METHODOLOGY

    #

    METHODOLOGY

    Azoth Analytics creates in-depth research reports by recording, interpreting and analyzing information through primary and secondary research. Our strategic market sizing and data dredging techniques include secondary research, interviews with key market players and industry experts and use of industry specific statistical tools which helps in designing and planning effective research for our global and local clients.

    Read More
  4. Consulting

    #

    Consulting

    Azoth Analytics Consulting assists clients across the globe to enter, progress, and develop in the targeted market through our fact-based business intelligence. We deliver practical and implementable solutions to our domestic and international clients. Our analysts are skilled with techniques of data gathering, market sizing, forecasting, analyzing and providing competitive intelligence and provide progressive research in verticals including healthcare & pharmaceutical...

    Read More
  5. media center

    #

    media center

    Our business research and market analysis helps organizations across different industry verticals solve their business problems. We are always scrupulous about our work and provide customized market research reports revealing the hidden truths on different verticals like pharmaceutical, oil and gas, telecommunications, real estate, logistics, energy, healthcare, technology, FMCG, food & beverages and media sectors.

    Read More
news

     Home >> Research Report >> Healthcare & Pharma >> Global Assisted Reproductive Technology (ART) Market - Analysis By Technology (IVF, Artificial Insemination, Others), Products, End User, By Region, By Country (2020 Edition): Market Insight, Competition and Forecast (2020-2025)
 

Global Assisted Reproductive Technology (ART) Market - Analysis By Technology (IVF, Artificial Insemination, Others), Products, End User, By Region, By Country (2020 Edition): Market Insight, Competition and Forecast (2020-2025)-.

 
Publish Date:February 2020
No. of Pages:220
Format: Pdf (Instant Download)
 
 
Social
Electronic Access - Single User License toll
$2000
 
Electronic Access - Multi User License toll
$3000
 
Hard Copy Mail Delivery toll
$2200
 
 
Executive Summary

Global Assisted Reproductive Technology Market was valued at USD 24133.23 Million in the year 2019. Delay in age of first time pregnancy has led to lowering of total fertility rate (TFR) globally. Growing stress levels, escalation in pollution levels, modern lifestyle with increase in alcohol consumption and smoking are all cumulatively leading to increase in male and female infertility. Acceptance of homosexual couples and single mothers surging in number for use of ART are anticipated to lead market growth in the forecast period of 2020-2025.

Various techniques such as In Vitro fertilization (IVF), Artificial Insemination, Zygote Intra-fallopian transfer (ZIFT), Gamete Intra-fallopian Transfer (GIFT) are used according to need of the patient. In Vitro fertilization is considered as Gold standard for ART due to high success rate for embryo transfer and increase in live birth rates. Drugs such as orals and hormones which are injectable, are used prior to ART treatment and also during the treatment to prepare the body. Drugs market is estimated to grow heavily with elaborate pipeline. Moreover, INVOcell and Anecova have developed In vivo ART devices, which are likely to facilitate market growth in the forecast period.

Among the regions, Asia Pacific, followed by Europe and Americas, will experience the highest growth rate owing to decrease in male and female fertility. 

Scope of the Report

• The report analyses Assisted Reproductive Technology Market at global, regional and country-levels.
• The report analyses Assisted Reproductive Technology Market By Technology (In vitro Fertilization, Artificial Insemination, Others).
• The report assesses the Assisted Reproductive Technology Market By End User (Hospitals, Fertility clinics).
• The report assesses the Assisted Reproductive Technology Market By Products (Consumables, Instruments, Software and Services, Drugs).
• The Global Assisted Reproductive Technology Market has been analysed By Region (Americas, Europe, Asia Pacific) and By Country (USA, Canada, Brazil, Mexico, China, Japan, India, UK, Germany, Italy).
• The key insights of the report have been presented through the frameworks of Key developments and drug pipeline phases. Also, the attractiveness of the market has been presented by Technology, End User, Products and Region. Additionally, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report. 
• The companies analysed in the report include Merck, Hamilton Thorne, Cooper Surgical, Nidacon International AB, Anecova, Esco, INVO Bioscience, Monash IVF Group, Irvine Scientific.
• The report presents the analysis of Assisted Reproductive Technology market for the historical period of 2015-2019 and the forecast period of 2020-2025.

Key Target Audience
• Pharmaceutical Firms
• IVF Clinics and Hospitals
• Consulting and Advisory Firms
• Medical Practitioners
1. Research Methodology and Executive Summary
1.1 Research Methodology
1.2 Executive Summary

2. Strategic Recommendations
2.1 Focus on Development of Low Cost Technology
2.2 Focus on Emerging Markets

3. Assisted Reproductive Technology Market: Product Outlook

4. Global Assisted Reproductive Technology Market: Sizing and Forecast
4.1 Market Size, By Value, Year 2015-2025

5. Global ART Market Segmentation - By Technology
5.1  Competitive Scenario of Global ART: By Technology
5.2 IVF – Market Size and Forecast (2015-2025)
5.3 AI - Market Size and Forecast (2015-2025)
5.4 Others - Market Size and Forecast (2015-2025)

6. Global ART Market Segmentation - By End User
6.1  Competitive Scenario of Global ART: By End User
6.2 Hospitals & Others – Market Size and Forecast (2015-2025)
6.3 Fertility Clinics – Market Size and Forecast (2015-2025)

7. Global ART Market Segmentation - By Product Type
7.1  Competitive Scenario of Global ART: By Product Type
7.2 Drugs – Market Size and Forecast (2015-2025)
7.3 Instruments – Market Size and Forecast (2015-2025)
7.4 Consumables – Market Size and Forecast (2015-2025)
7.5 Software & Services – Market Size and Forecast (2015-2025)

8. Global Assisted Reproductive Technology Market: Regional Analysis
8.1 Competitive Scenario of Global ART: By Region

9. Americas ART Market: Segmentation By Technology, End User, Product Type (2015-2025)

9.1 Americas ART Market: Size and Forecast (2015-2025), By Value
9.2 Americas ART Market – Prominent Companies
9.3 Market Segmentation By Technology (IVF, AI and Others)
9.4 Market Segmentation By End User (Hospitals & Others, Fertility Clinics)
9.5 Market Segmentation By Product Type (Consumables, Instruments, Drugs, Software & Services)

9.6 Americas ART Market: Country Analysis

9.7 Market Opportunity Chart of Americas ART Market - By Country, By Value, 2025
9.8 Competitive Scenario of Americas ART: By Country, Year 2019 & 2025
9.9 United States ART Market: Size and Forecast (2015-2025), By Value
9.10 United States ART Market Segmentation - By Technology, By End User, By Product Type
9.11 Canada ART Market: Size and Forecast (2015-2025), By Value
9.12 Canada ART Market Segmentation - By Technology, By End User, By Product Type
9.13 Mexico ART Market: Size and Forecast (2015-2025), By Value
9.14 Mexico ART Market Segmentation - By Technology, By End User, By Product Type
9.15 Brazil ART Market: Size and Forecast (2015-2025), By Value
9.16 Brazil ART Market Segmentation - By Technology, By End User, By Product Type

10.  Europe ART Market: Segmentation By Technology, End User, Product Type (2015-2025)

10.1 Europe ART Market: Size and Forecast (2015-2025), By Value
10.2 Europe ART Market – Prominent Companies
10.3 Market Segmentation By Technology (IVF, AI and Others)
10.4 Market Segmentation By End User (Hospitals & Others, Fertility Clinics)
10.5 Market Segmentation By Product Type (Consumables, Instruments, Drugs, Software &   Services)

10.6 Europe ART Market: Country Analysis

10.7 Market Opportunity Chart of Europe ART Market - By Country, By Value, 2025
10.8 Competitive Scenario of Europe ART: By Country, Year 2019 & 2025
10.9 Germany ART Market: Size and Forecast (2015-2025), By Value
10.10 Germany ART Market Segmentation - By Technology, By End User, By Product Type
10.11 United Kingdom ART Market: Size and Forecast (2015-2025), By Value
10.12 United Kingdom ART Market Segmentation - By Technology, By End User, By Product Type
10.13 Italy ART Market: Size and Forecast (2015-2025), By Value
10.14 Italy ART Market Segmentation - By Technology, By End User, By Product Type

11.  Asia Pacific ART Market: Segmentation By Technology, End User, Product Type (2015-2025)

11.1 Asia Pacific ART Market: Size and Forecast (2015-2025), By Value
11.2 Asia Pacific ART Market – Prominent Companies
11.3 Market Segmentation By Technology (IVF, AI and Others)
11.4 Market Segmentation By End User (Hospitals & Others, Fertility Clinics)
11.5 Market Segmentation By Product Type (Consumables, Instruments, Drugs, Software & Services)

11.6 Asia Pacific ART Market: Country Analysis
11.7 Market Opportunity Chart of Asia Pacific ART Market - By Country, By Value, 2025
11.8 Competitive Scenario of Asia Pacific ART: By Country, Year 2019 & 2025
11.9 China ART Market: Size and Forecast (2015-2025), By Value
11.10 China ART Market Segmentation - By Technology, By End User, By Product Type
11.11 Japan ART Market: Size and Forecast (2015-2025), By Value
11.12 Japan ART Market Segmentation - By Technology, By End User, By Product Type
11.13 India ART Market: Size and Forecast (2015-2025), By Value
11.14 India ART Market Segmentation - By Technology, By End User, By Product Type

12. Global Assisted Reproductive Technology Market Dynamics
12.1 Drivers
12.2 Restraints
12.3 Trends

13. Market Attractiveness
13.1 Market Attractiveness Chart of Global ART Market - By Technology Segment, 2025
13.2 Market Attractiveness Chart of Global ART Market - By End User Segment, 2025
13.3 Market Attractiveness Chart of Global ART Market - By Product Type Segment, 2025
13.4 Market Attractiveness Chart of Global ART Market - By Region Segment, 2025

14. Key Developments in Assisted Reproductive Technology Market

15. Assisted Reproductive Technology Pipeline

16. Competitive Landscape and Market Share Analysis
16.1 Market Share of Leading Global Companies
16.2 Competitive Position of companies dealing in ART

17. Company Analysis
17.1 Irvine Scientific
17.2 Merck
17.3 Hamilton Thorne
17.4 Vitrolife
17.5 Monash IVF Group
17.6 INVO Bioscience
17.7 Cooper Surgical
17.8 Esco
17.9 Anecova
17.10 Nidacon International AB

List of Figures

Figure 1: Global ART Market Size, By Value, 2015-2025 (USD Million)
Figure 2: Global Male Infertility Prevalence Rate, 2014 – 2017 (per 100k)
Figure 3: Global Female Infertility Prevalence Rate, 2014 – 2017 (per 100k)
Figure 4: Global Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
Figure 5: Overweight Population aged 15+ in G7 countries, 2017 (%)
Figure 6: Global Total Fertility Rate, 2014 - 2017 (Births/Woman)
Figure 7: Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
Figure 8: Global ART Market, By Technology, year 2019 & 2025
Figure 9: Global Assisted Reproductive Technology Market – By IVF , By Value (USD Million), 2015-2025
Figure 10: Global Assisted Reproductive Technology Market – By AI , By Value (USD Million), 2015-2025 
Figure 11: Global Assisted Reproductive Technology Market – By Others, By Value (USD Million), 2015-2025
Figure 12: Global ART Market, By End User, Year 2019 & 2025
Figure 13: Global Assisted Reproductive Technology Market – By Hospitals & Others, By Value (USD Million), 2015-2025 
Figure 14: Global Assisted Reproductive Technology Market – By Fertility Clinics, By Value (USD Million), 2015-2025 
Figure 15: Global ART Market, By Product Type, Year 2019 & 2025
Figure 16: Global Assisted Reproductive Technology Market – By Drugs, By Value (USD Million), 2015-2025 
Figure 17: Global Assisted Reproductive Technology Market – By Instruments, By Value (USD Million), 2015-2025 
Figure 18: Global Assisted Reproductive Technology Market – By Consumables, By Value (USD Million), 2015-2025 
Figure 19: Global Assisted Reproductive Technology Market – By Software and Services, By Value (USD Million), 2015-2025 
Figure 20: Regional ART Market, Year 2019 & 2025
Figure 21: Americas Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
Figure 22: Americas Male Infertility Prevalence Rate, 2014 – 2017 (per 100k)
Figure 23: Americas Female Infertility Prevalence Rate, 2014 – 2017 (per 100k)
Figure 24: Americas Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
Figure 25: Americas Total Fertility Rate, 2014 - 2017 (Births/Woman)
Figure 26: Latin America and Caribbean Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
Figure 27: North America and Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
Figure 28: Americas Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
Figure 29: Americas Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
Figure 30: Americas Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 31: Market Opportunity Chart of Americas Assisted Reproductive Technology Market - By Country, By Value (Year-2025)
Figure 32: Americas ART, By Country, Year 2019 & 2025
Figure 33: United States Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
Figure 34: United States Male Infertility Prevalence Rate, 2014 – 2017 (per 100k)
Figure 35: United States Female Infertility Prevalence Rate, 2014 – 2017 (per 100k)
Figure 36: United States Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
Figure 37: United States Total Fertility Rate, 2014 - 2017 (Births/Woman)
Figure 38: United States Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
Figure 39: United States Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
Figure 40: United States Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
Figure 41: United States Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 42: Canada Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
Figure 43: Canada Male Infertility Prevalence Rate, 2014 – 2017 (per 100k)
Figure 44: Canada Female Infertility Prevalence Rate, 2014 – 2017 (per 100k)
Figure 45: Canada Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
Figure 46: Canada Total Fertility Rate, 2014 - 2017 (Births/Woman)
Figure 47: Canada Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
Figure 48: Canada Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
Figure 49: Canada Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
Figure 50: Canada Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 51: Mexico Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
Figure 52: Mexico Male Infertility Prevalence Rate, 2014 – 2017 (per 100k)
Figure 53:  Mexico Female Infertility Prevalence Rate, 2014 – 2017 (per 100k)
Figure 54: Mexico Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
Figure 55: Mexico Total Fertility Rate, 2014 - 2017 (Births/Woman)
Figure 56: Mexico Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
Figure 57: Mexico Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
Figure 58: Mexico Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
Figure 59: Mexico Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 60: Brazil Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
Figure 61: Brazil Male Infertility Prevalence Rate, 2014 – 2017 (per 100k
Figure 62: Brazil Female Infertility Prevalence Rate, 2014 – 2017 (per 100k)
Figure 63: Brazil Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
Figure 64: Brazil Total Fertility Rate, 2014 - 2017 (Births/Woman)
Figure 65: Brazil Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
Figure 66: Brazil Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
Figure 67: Brazil Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
Figure 68: Brazil Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 69: Europe Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
Figure 70: Europe Male Infertility Prevalence Rate, 2014 – 2017 (per 100k)
Figure 71: Europe Female Infertility Prevalence Rate, 2014 – 2017 (per 100k)
Figure 72: Europe Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
Figure 73: European Union Total Fertility Rate, 2014 - 2017 (Births/Woman)
Figure 74: Europe Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
Figure 75: Europe total fertility rate(children/woman),2017
Figure 76: Europe Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
Figure 77: Europe Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
Figure 78: Europe Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 79: Market Opportunity Chart of Europe Assisted Reproductive technology Market - By Country, By Value, 2025
Figure 80: Europe ART, By Country, Year 2019 & 2025
Figure 81: Germany Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
Figure 82: Germany Male Infertility Prevalence Rate, 2014 – 2017 (per 100k)
Figure 83: Germany Female Infertility Prevalence Rate, 2014 – 2017 (per 100k)
Figure 84: Germany Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
Figure 85: Germany Total Fertility Rate, 2014 - 2017 (Births/Woman)
Figure 86: Germany Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
Figure 87: Germany Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
Figure 88: Germany Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
Figure 89: Germany Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 90: United Kingdom Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
Figure 91: UK Male Infertility Prevalence Rate, 2014 – 2017 (per 100k)
Figure 92: UK Female Infertility Prevalence Rate, 2014 – 2017 (per 100k)
Figure 93: UK Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
Figure 94: UK Total Fertility Rate, 2014 - 2017 (Births/Woman)
Figure 95: United Kingdom Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
Figure 96: UK Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
Figure 97: UK Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
Figure 98: UK Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 99: Italy Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
Figure 100: Italy Male Infertility Prevalence Rate, 2014 – 2017 (per 100k)
Figure 101: Italy Female Infertility Prevalence Rate, 2014 – 2017 (per 100k)
Figure 102: Italy Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
Figure 103: Italy Total Fertility Rate, 2014 - 2017 (Births/Woman)
Figure 104: Italy Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
Figure 105: Italy Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
Figure 106: Italy Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
Figure 107: Italy Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 108: Asia Pacific Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
Figure 109: Asia Pacific Male Infertility Prevalence Rate, 2014 – 2017 (per 100k)
Figure 110: Asia Pacific Female Infertility Prevalence Rate, 2014 – 2017 (per 100k)
Figure 111: Asia Pacific Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
Figure 112: Asia Pacific Total Fertility Rate, 2014 - 2017 (Births/Woman)
Figure 113: Asia Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
Figure 114: Asia Pacific Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
Figure 115: Asia Pacific Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
Figure 116: Asia Pacific Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 117: Market Opportunity Chart of Asia Pacific ART Market - By Country, By Value, 2025
Figure 118: Asia Pacific ART, By Country, Year 2019 & 2025
Figure 119: China Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
Figure 120: China Male Infertility Prevalence Rate, 2014 – 2017 (per 100k)
Figure 121: China Female Infertility Prevalence Rate, 2014 – 2017 (per 100k)
Figure 122: China Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
Figure 123: China Total Fertility Rate, 2014 - 2017 (Births/Woman)
Figure 124: China Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
Figure 125: China Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
Figure 126: China Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
Figure 127: China Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 128: Japan Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
Figure 129: Japan Male Infertility Prevalence Rate, 2014 – 2017 (per 100k)
Figure 130: Japan Female Infertility Prevalence Rate, 2014 – 2017 (per 100k)
Figure 131: Japan Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
Figure 132: Japan Total Fertility Rate, 2014 - 2017 (Births/Woman)
Figure 133: Japan Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
Figure 134: Japan Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
Figure 135: Japan Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
Figure 136: Japan Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 137: India Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
Figure 138: India Male Infertility Prevalence Rate, 2014 – 2017 (per 100k)
Figure 139: India Female Infertility Prevalence Rate, 2014 – 2017 (per 100k)
Figure 140: India Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
Figure 141: India Total Fertility Rate, 2014 - 2017 (Births/Woman)
Figure 142: India Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
Figure 143: India Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
Figure 144: India Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
Figure 145: India Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 146: Market Attractiveness Chart of Global ART Market - By Technology Segment, 2025
Figure 147: Market Attractiveness Chart of Global ART Market - By End User, 2025
Figure 148: Market Attractiveness Chart of Global ART Market - By Product Type, By Value, 2025
Figure 149: Market Attractiveness Chart of Global ART Market - By Region, By Value, 2025
Figure 150: Market Share of Leading Global Assisted Reproductive Technology Companies, 2018 (In %)
Figure 151: Competitive Positions of companies dealing in Assisted Reproductive Technology (2018)
Figure 152: Merck Revenue, 2014-2018 (In USD Million)
Figure 153: Merck Revenue, By Region, 2017 (In %)
Figure 154: Merck  Revenue, By Region, 2018 (In %)
Figure 155: Merck Revenue, By Business Segment, 2017 (In %)
Figure 156: Merck  Revenue, By Business Segment, 2018 (In %)
Figure 157: Hamilton Thorne Sales Revenue, 2014 - 2018 (In USD Million)
Figure 158: Hamilton Thorne Net Income, 2014 - 2018 (In USD Million)
Figure 159: Hamilton Thorne Segment Sales Revenue, 2017 (In %)
Figure 160: Hamilton Thorne Segment Sales   Revenue, 2018 (In %)
Figure 161: Vitrolife Net Sales, 2014 - 2018 (In USD Million)
Figure 162: Vitrolife Net Income, 2014-2018(In USD Million) 
Figure 163: Vitrolife Net Sales, By Region, 2018 (In %)
Figure 164: Vitrolife Net Sales, By Business Sector, 2018 (In %)
Figure 165: Vitrolife Net Sales By Products and Services, 2018 (In %)
Figure 166: Monash IVF Group Revenue, 2015 - 2019 (In USD Million)
Figure 167: Monash IVF Group Revenue, By Region, 2018 (In %)
Figure 168: Monash IVF Group Revenue, By Region, 2019 (In %) 
Figure 169: INVO Bioscience Revenue, 2014 - 2018 (In USD Thousands)
Figure 170: INVO Bioscience, Net Loss, 2014-2018(In Thousands)
Figure 171: Cooper Companies Inc. & Subsidiaries, Net Sales 2015-2019 (In USD Million)
Figure 172: Cooper Surgical Net Sales 2015-2019(In USD Million)
Figure 173: Cooper Surgical Net Sales By Category, 2019, (%)
Figure 174: Cooper Surgical Net Sales By Category, 2018, (%)

List of Tables

Table A: Fertility Drugs Used during Assisted Reproductive Treatment
Table B: Global Market Share Analysis of Companies 
One can also purchase any particular sections from this report. Please send us an email to info@azothanalytics.com with your order details.
 
 
 
 
 Latest Market Research Reports